RhythmAnalytics vs DeepRhythmAI

Direct competitors — feature-level head-to-head below. Comparability 95/100 Comparability is an AI-graded 0–100 score of how directly these two tools compete — higher means a more apples-to-apples comparison.

RhythmAnalytics

by Biofourmis Singapore Pte.

DeepRhythmAI

by Medicalgorithmics S.A.

AI Verdict

Both RhythmAnalytics and DeepRhythmAI are FDA-cleared, cloud-based AI solutions designed for automated cardiac arrhythmia interpretation and detection from ECG data, providing clinical decision support. While RhythmAnalytics details specific ECG analysis components and compatibility with various FDA-cleared devices, DeepRhythmAI highlights its advanced AI models and quantifiable improvements in diagnostic accuracy and workflow efficiency. Both serve as direct competitors for healthcare providers seeking to enhance arrhythmia diagnostics.

Choose RhythmAnalytics if…

Choose RhythmAnalytics if your primary need is detailed, beat-by-beat analysis and precise detection of over 15 specific types of cardiac arrhythmias from single-lead ECG data. This tool is ideal for healthcare providers seeking granular ECG signal processing, QRS feature extraction, and rhythm analysis, especially when integrating with a diverse range of FDA-cleared Holter, event recorders, or wearable ECG sensors.

View RhythmAnalytics →

Choose DeepRhythmAI if…

Choose DeepRhythmAI if your priority is to revolutionize cardiac arrhythmia diagnostics with superior accuracy and efficiency, significantly reducing missed diagnoses and streamlining clinical workflows. This solution is best suited for organizations that require a device-agnostic, cloud-based AI algorithm trained on an exceptionally large dataset to provide rapid and highly reliable arrhythmia detection and classification across various ECG devices.

View DeepRhythmAI →

When choosing between RhythmAnalytics by Biofourmis and DeepRhythmAI by Medicalgorithmics, physicians should consider their specific needs for cardiac arrhythmia interpretation. RhythmAnalytics excels in providing automated, detailed interpretation of cardiac arrhythmias from single-lead ECG data, offering clinical decision support across a broad spectrum of over 15 arrhythmia types. Its key features include beat-by-beat morphology computation, comprehensive ECG signal processing, and compatibility with various FDA-cleared ECG devices, making it suitable for specialties like Cardiology, Emergency Medicine, and Internal Medicine.

DeepRhythmAI, on the other hand, focuses on revolutionizing cardiac arrhythmia detection and classification with superior accuracy and efficiency, leveraging advanced CNN and Transformer models trained on an extensive dataset of over 250 billion annotated heartbeats. While both are FDA-cleared and cloud-based, a key practical difference lies in DeepRhythmAI’s emphasis on reducing missed diagnoses significantly (14x to 114x fewer) and streamlining clinical workflows with up to a 65% efficiency increase. Physicians prioritizing a broad range of detailed arrhythmia interpretations and device compatibility for diverse clinical settings may lean towards RhythmAnalytics. Conversely, those seeking highly accurate detection, classification, and substantial workflow efficiencies, particularly within cardiology, might find DeepRhythmAI to be the more compelling choice.

Reviewed by Pouyan Golshani, MD — Interventional Radiologist

Quick Comparison

Feature	RhythmAnalytics	DeepRhythmAI
Pricing	Contact vendor	Enterprise
Deployment	Cloud-based API	Cloud
FDA Status	1 AI-estimated	Cleared AI-estimated

Head-to-Head

AI-generated assessment across six dimensions based on each tool's documented features and compliance posture. Grounded in public data — not a substitute for hands-on evaluation.

Usability

DeepRhythmAI

DeepRhythmAI, particularly through its DeepRhythm Platform, explicitly highlights an 'intuitive user interface' and significant workflow efficiency improvements, claiming up to a 65% increase in streamlining clinical workflows and faster reporting for physicians and technicians. While RhythmAnalytics is cloud-based and offers API integration, its description focuses more on integration capabilities for developers rather than direct end-user workflow enhancements.

Clinical Value

DeepRhythmAI

DeepRhythmAI demonstrates superior clinical value, evidenced by the DRAI MARTINI study published in Nature Medicine, which reported 14 to 114 times fewer missed diagnoses of critical arrhythmias compared to human technicians. Its training on an unparalleled 250 billion+ annotated heartbeats also suggests a more robust and comprehensive detection capability. RhythmAnalytics, while FDA-cleared and effective, does not present comparable quantified clinical superiority from independent, large-scale studies.

Pricing & Value

DeepRhythmAI

Both tools require direct vendor contact for pricing, making a direct cost comparison impossible. However, DeepRhythmAI provides a clearer value proposition by explicitly quantifying benefits such as 'streamlining clinical workflows by up to 65%' and 'reducing missed diagnoses (14x to 114x fewer)', which directly translate to significant operational efficiencies and improved patient outcomes.

Enterprise Readiness

DeepRhythmAI

DeepRhythmAI exhibits stronger enterprise readiness, explicitly stating its target size from 'solo to large health systems' and 'numerous healthcare providers globally'. It also boasts comprehensive compliance certifications including ISO/IEC 27001, HIPAA, GDPR, HITECH, and SOC 2, and supports a wider array of data standards (FHIR, HL7 v2, DICOM, SNOMED, ICD-10) for seamless EMR integration.

Innovation

DeepRhythmAI

DeepRhythmAI stands out for its explicit use of advanced AI models, specifically CNN and Transformer models, and its training on an exceptionally large dataset of 250 billion+ annotated heartbeats. The independent DRAI MARTINI study, published in Nature Medicine, further solidifies its innovative edge by describing it as a 'paradigm shift' in ECG analysis.

Support & Docs

Tie

Neither RhythmAnalytics nor DeepRhythmAI provides sufficient public information regarding dedicated customer support channels, service level agreements (SLAs), or comprehensive documentation specifically for their AI platforms. While Medicalgorithmics (Tool B) has general user manuals for its devices and a technical email, this is not enough to distinguish it significantly for the AI tool itself.

Feature-by-Feature

Detail beyond the Quick Comparison summary. For pricing, deployment, BAA, FDA, and HIPAA see the Overview tab.

Feature	RhythmAnalytics	DeepRhythmAI
Name	RhythmAnalytics	DeepRhythmAI
Company	Biofourmis Singapore Pte.	Medicalgorithmics S.A.
Tagline	AI-powered automated interpretation of cardiac arrhythmias for enhanced clinical decision support.	Revolutionizing cardiac arrhythmia diagnostics with AI-powered ECG analysis.
Categories	Cardiology AI, Clinical Decision Support & Reference	Cardiology AI, Clinical Decision Support & Reference
Specialties	Cardiology, Emergency Medicine, Internal Medicine	Cardiology
Key Features	AI-based automated interpretation of cardiac arrhythmias; Detection of over 15 types of cardiac arrhythmias (including AFib, ventricular arrhythmias, ectopic beats); Beat-by-beat morphology computation; ECG signal processing and analysis; QRS and Ventricular Ectopic Beat detection; QRS feature extraction, interval measurement, heart rate measurement, and rhythm analysis; Cloud-based API for integration; Compatibility with FDA-cleared ECG devices (Holter, event recorders, wearable sensors)	AI-powered arrhythmia detection and classification; Utilizes CNN and Transformer models; Trained on 250 billion+ annotated heartbeats; Device-agnostic and integrates with various ECG devices; Cloud-based software; Faster ECG reporting and analysis; Reduces missed diagnoses (14x to 114x fewer); Streamlines clinical workflows (up to 65% efficiency increase)

Videos

Demos, reviews, and walkthroughs featuring RhythmAnalytics and DeepRhythmAI.

Loading videos…

Videos need JavaScript to load. Search YouTube directly →

View all on YouTube

Frequently Asked Questions

What specific types of cardiac arrhythmias can each tool detect?

RhythmAnalytics by Biofourmis is designed for the automated interpretation of over 15 types of cardiac arrhythmias, including AFib, ventricular arrhythmias, and ectopic beats, and performs beat-by-beat morphology computation. DeepRhythmAI by Medicalgorithmics S.A. offers AI-powered cardiac arrhythmia detection and classification, but the specific number or types of arrhythmias detected are not enumerated in the provided information.

Do these tools offer any quantifiable improvements in diagnosis or workflow efficiency?

DeepRhythmAI claims to significantly reduce missed diagnoses by 14x to 114x and improve clinical workflow efficiency by up to 65%, leading to faster ECG reporting and analysis. RhythmAnalytics focuses on providing AI-powered automated interpretation and clinical decision support, but the provided information does not include specific quantifiable improvements in diagnosis or workflow efficiency.

What are the underlying AI technologies and training data used by each tool?

DeepRhythmAI utilizes CNN and Transformer models and was trained on over 250 billion annotated heartbeats. RhythmAnalytics is described as an AI-powered software for automated interpretation, but the specific AI models used or the size of its training dataset are not detailed in the provided information.

How do these tools integrate with existing ECG devices and clinical systems?

Both RhythmAnalytics and DeepRhythmAI are cloud-based and offer an API for integration. RhythmAnalytics is compatible with FDA-cleared ECG devices such as Holter, event recorders, and wearable sensors, while DeepRhythmAI is described as device-agnostic and integrates with various ECG devices.